Search Results Search Sort by RelevanceMost Recent AMA Code Says Jul 2017 AMA Code of Medical Ethics’ Opinions on Patient Decision-Making Capacity and Competence and Surrogate Decision Making Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics' opinions related to decision-making capacity and competence and surrogate decision making. AMA J Ethics. 2017;19(7):675-677. doi: 10.1001/journalofethics.2017.19.7.coet1-1707. Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 1 Stephen Corey, MD and Peter Bulova, MD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):373-378. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. Case and Commentary Apr 2016 Considering Decision Making and Sexuality in Menstrual Suppression of Teens and Young Adults with Intellectual Disabilities Kruti Acharya, MD and John D. Lantos, MD A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit. AMA J Ethics. 2016;18(4):365-372. doi: 10.1001/journalofethics.2016.18.4.ecas2-1604. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Case and Commentary Feb 2019 Should Watson Be Consulted for a Second Opinion? David D. Luxton, PhD, MS Guidance for organizations using AI tools to diagnose and to develop treatment recommendations can also help clinicians consider risks and benefits. AMA J Ethics. 2019;21(2):E131-137. doi: 10.1001/amajethics.2019.131. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
AMA Code Says Jul 2017 AMA Code of Medical Ethics’ Opinions on Patient Decision-Making Capacity and Competence and Surrogate Decision Making Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics' opinions related to decision-making capacity and competence and surrogate decision making. AMA J Ethics. 2017;19(7):675-677. doi: 10.1001/journalofethics.2017.19.7.coet1-1707.
Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 1 Stephen Corey, MD and Peter Bulova, MD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):373-378. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
Case and Commentary Apr 2016 Considering Decision Making and Sexuality in Menstrual Suppression of Teens and Young Adults with Intellectual Disabilities Kruti Acharya, MD and John D. Lantos, MD A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit. AMA J Ethics. 2016;18(4):365-372. doi: 10.1001/journalofethics.2016.18.4.ecas2-1604.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Case and Commentary Feb 2019 Should Watson Be Consulted for a Second Opinion? David D. Luxton, PhD, MS Guidance for organizations using AI tools to diagnose and to develop treatment recommendations can also help clinicians consider risks and benefits. AMA J Ethics. 2019;21(2):E131-137. doi: 10.1001/amajethics.2019.131.